A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer. (Q46035584)
Jump to navigation
Jump to search
scientific article published in December 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer. |
scientific article published in December 2006 |
Statements
1 reference
A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer. (English)
1 reference
1 reference
Electron Kebebew
1 reference
Quan-Yang Duh
1 reference
Orlo H Clark
1 reference
Patrick Treseler
1 reference
Eugene Morita
1 reference
Miao Peng
1 reference
Kenneth A Woeber
1 reference
Francis S Greenspan
1 reference
Sheila Lindsay
1 reference
1 December 2006
1 reference
1 reference
140
1 reference
6
1 reference
960-6; discussion 966-7
1 reference